PREDNISOLONE SODIUM PHOSPHATE

PREDNISOLONE SODIUM PHOSPHATE was reported 2492 times

PREDNISOLONE SODIUM PHOSPHATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PARECHOVIRUS INFECTION 3 0.2727
1 MENINGOMYELITIS HERPES 5 0.1562
2 HEART SOUNDS 15 0.1562
3 CHOROIDITIS 56 0.1497
4 ENCEPHALITIC INFECTION 4 0.1081
5 INVOLUNTARY VOCALISATION 2 0.0690
6 DOLICHOCOLON 5 0.0610
7 PROLONGED EXPIRATION 15 0.0573
8 NEUROLOGIC NEGLECT SYNDROME 31 0.0558
9 NOCARDIA SEPSIS 3 0.0556
10 HYPONATRAEMIC SEIZURE 11 0.0433
11 DYSSOMNIA 8 0.0417
12 MICROLITHIASIS 3 0.0417
13 LENTIGO MALIGNA STAGE UNSPECIFIED 2 0.0392
14 CAROTID ARTERY THROMBOSIS 32 0.0377
15 TENDER JOINT COUNT 3 0.0357
16 TOTAL LUNG CAPACITY ABNORMAL 13 0.0334
17 CORNEAL THICKENING 2 0.0294
18 FOETAL MOVEMENTS DECREASED 3 0.0294
19 HEPATITIS B REACTIVATION 93 0.0293
20 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE 3 0.0286
21 PULMONARY VASCULITIS 14 0.0260
22 ADJUSTMENT DISORDER 31 0.0238
23 CHONDRITIS 4 0.0230
24 NASAL FLARING 3 0.0222
25 SPIROMETRY ABNORMAL 13 0.0217
26 CAPILLARITIS 6 0.0217
27 HAEMODILUTION 2 0.0202
28 TEMPERATURE REGULATION DISORDER 44 0.0197
29 CHORIORETINOPATHY 28 0.0197
30 STEROID DEPENDENCE 17 0.0194
31 CATARRH 17 0.0188
32 PLACENTAL INFARCTION 4 0.0179
33 RETINAL NEOVASCULARISATION 4 0.0159
34 SCLERODERMA RENAL CRISIS 6 0.0158
35 CUTANEOUS NOCARDIOSIS 2 0.0154
36 WEGENER'S GRANULOMATOSIS 3 0.0150
37 BOWEN'S DISEASE 2 0.0147
38 EYE ABSCESS 4 0.0131
39 CORNEAL DECOMPENSATION 2 0.0124
40 KERATITIS BACTERIAL 2 0.0123
41 SQUAMOUS CELL CARCINOMA OF THE TONGUE 5 0.0122
42 SWOLLEN JOINT COUNT 3 0.0120
43 PERSONALITY DISORDER 31 0.0118
44 GINGIVAL HYPERPLASIA 7 0.0117
45 ENTEROCOCCAL SEPSIS 9 0.0111
46 AVERSION 3 0.0104
47 ENDOPHTHALMITIS 61 0.0102
48 TONSILLAR DISORDER 11 0.0098
49 BURNS SECOND DEGREE 17 0.0097
50 BRONCHOALVEOLAR LAVAGE ABNORMAL 2 0.0096
51 ACROMEGALY 3 0.0095
52 CORNEAL DEPOSITS 7 0.0094
53 CANDIDA PNEUMONIA 3 0.0093
54 DISSEMINATED CYTOMEGALOVIRAL INFECTION 2 0.0093
55 MENINGITIS CRYPTOCOCCAL 16 0.0091
56 FOETAL DEATH 45 0.0087
57 CORONARY ARTERY ANEURYSM 2 0.0085
58 ALVEOLAR PROTEINOSIS 5 0.0084
59 PHAEOHYPHOMYCOSIS 4 0.0084
60 CORNEAL DEGENERATION 2 0.0083
61 KERATOPATHY 13 0.0082
62 ALTERNARIA INFECTION 3 0.0081
63 CAVERNOUS SINUS THROMBOSIS 2 0.0079
64 C-REACTIVE PROTEIN 7 0.0076
65 SPLENIC ABSCESS 3 0.0074
66 NASAL OEDEMA 13 0.0072
67 PULMONARY VENO-OCCLUSIVE DISEASE 5 0.0071
68 FALSE NEGATIVE INVESTIGATION RESULT 5 0.0071
69 INFECTION IN AN IMMUNOCOMPROMISED HOST 5 0.0070
70 HEPATITIS E 11 0.0070
71 HEPATIC ARTERY THROMBOSIS 2 0.0068
72 HEART FAILURE WITH PRESERVED EJECTION FRACTION 2 0.0068
73 RIGHT VENTRICULAR HYPERTROPHY 6 0.0066
74 PROCTITIS ULCERATIVE 4 0.0066
75 COMPLICATIONS OF TRANSPLANTED LUNG 2 0.0065
76 MUSCLE ABSCESS 4 0.0064
77 ALCOHOL POISONING 17 0.0063
78 JUVENILE ARTHRITIS 2 0.0061
79 CONJUNCTIVITIS ALLERGIC 9 0.0061
80 HIRSUTISM 8 0.0060
81 KAPOSI'S SARCOMA 3 0.0060
82 COMPLICATIONS OF TRANSPLANT SURGERY 3 0.0059
83 NOCARDIOSIS 15 0.0059
84 CENTRAL SEROUS CHORIORETINOPATHY 4 0.0059
85 DYSPNOEA EXACERBATED 3 0.0058
86 FOOD ALLERGY 45 0.0058
87 ENTEROVIRUS INFECTION 5 0.0058
88 FUNGAEMIA 9 0.0057
89 CHRONIC RESPIRATORY DISEASE 2 0.0057
90 SCEDOSPORIUM INFECTION 4 0.0057
91 CYTOMEGALOVIRUS HEPATITIS 2 0.0056
92 CYTOMEGALOVIRUS ENTERITIS 2 0.0056
93 STRONGYLOIDIASIS 9 0.0056
94 HERPES ZOSTER MENINGOENCEPHALITIS 2 0.0056
95 ACUTE HEPATIC FAILURE 75 0.0055
96 INTRAOCULAR PRESSURE INCREASED 69 0.0054
97 GANGRENE 32 0.0053
98 HYPOPNOEA 18 0.0052
99 CORNEAL EPITHELIUM DEFECT 3 0.0052
100 DEEP VEIN THROMBOSIS POSTOPERATIVE 10 0.0050
101 ECTHYMA 2 0.0050
102 RESPIRATORY SYMPTOM 14 0.0049
103 ANTEPARTUM HAEMORRHAGE 2 0.0048
104 IMMOBILE 21 0.0048
105 PULMONARY VALVE INCOMPETENCE 7 0.0048
106 TRANSITIONAL CELL CARCINOMA 6 0.0046
107 MUCORMYCOSIS 12 0.0046
108 COELIAC DISEASE 45 0.0046
109 BURSITIS 54 0.0044
110 UVEITIS 60 0.0044
111 PUNCTATE KERATITIS 4 0.0044
112 CEREBRAL TOXOPLASMOSIS 4 0.0043
113 MATERNAL EXPOSURE TIMING UNSPECIFIED 16 0.0043
114 DEPRESSIVE SYMPTOM 15 0.0043
115 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 5 0.0042
116 ENCEPHALITIS HERPES 2 0.0040
117 DISSEMINATED CRYPTOCOCCOSIS 3 0.0040
118 BASOPHIL COUNT INCREASED 3 0.0040
119 SUSPECTED PRODUCT CONTAMINATION 4 0.0039
120 ARTERIAL OCCLUSIVE DISEASE 31 0.0039
121 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 20 0.0039
122 METASTATIC SQUAMOUS CELL CARCINOMA 2 0.0039
123 PULMONARY MYCOSIS 3 0.0039
124 SENSORY LOSS 31 0.0038
125 HEMIPLEGIA 32 0.0038
126 HYPHAEMA 2 0.0038
127 METAPNEUMOVIRUS INFECTION 3 0.0038
128 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 10 0.0038
129 INTESTINAL DILATATION 5 0.0037
130 BURSITIS INFECTIVE 2 0.0037
131 MEAN PLATELET VOLUME DECREASED 3 0.0036
132 AFFECT LABILITY 34 0.0035
133 ACTINIC KERATOSIS 9 0.0035
134 ABDOMINAL LYMPHADENOPATHY 3 0.0035
135 ENTERAL NUTRITION 2 0.0034
136 SWOLLEN JOINT COUNT INCREASED 11 0.0034
137 CELLULITIS ORBITAL 2 0.0034
138 LYMPHOPROLIFERATIVE DISORDER 10 0.0034
139 PARVOVIRUS B19 INFECTION 3 0.0034
140 IMMUNODEFICIENCY 50 0.0034
141 PARAINFLUENZAE VIRUS INFECTION 5 0.0033
142 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 3 0.0032
143 OPPORTUNISTIC INFECTION 6 0.0032
144 BONE GRAFT 3 0.0032
145 SLEEP-RELATED EATING DISORDER 3 0.0032
146 MOTOR DYSFUNCTION 32 0.0031
147 DISSEMINATED TUBERCULOSIS 8 0.0031
148 OESOPHAGEAL DISORDER 12 0.0031
149 INTRA-UTERINE DEATH 5 0.0031
150 MITE ALLERGY 2 0.0031
151 LARGE INTESTINAL STENOSIS 6 0.0030
152 RHEUMATOID FACTOR POSITIVE 17 0.0029
153 MUSCLE SPASTICITY 36 0.0029
154 CONJUNCTIVAL OEDEMA 3 0.0029
155 FOETAL HYPOKINESIA 2 0.0029
156 TRANSPLANT FAILURE 7 0.0029
157 X-RAY ABNORMAL 5 0.0028
158 PRESCRIBED OVERDOSE 54 0.0028
159 SYSTEMIC CANDIDA 7 0.0028
160 AMNIOTIC CAVITY INFECTION 2 0.0028
161 FACET JOINT SYNDROME 9 0.0028
162 RALES 16 0.0028
163 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 2 0.0027
164 EPSTEIN-BARR VIRUS INFECTION 17 0.0027
165 CENTRAL OBESITY 2 0.0027
166 LOWER LIMB FRACTURE 52 0.0027
167 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 3 0.0027
168 HISTIOCYTOSIS HAEMATOPHAGIC 8 0.0027
169 PERIPHERAL VENOUS DISEASE 11 0.0027
170 PNEUMOCYSTIS JIROVECI PNEUMONIA 6 0.0027
171 RHEUMATIC FEVER 12 0.0027
172 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 6 0.0027
173 BRONCHIECTASIS 18 0.0027
174 STEROID DIABETES 4 0.0027
175 SUBCLAVIAN VEIN THROMBOSIS 3 0.0026
176 DILATATION ATRIAL 3 0.0026
177 GLOMERULONEPHRITIS MEMBRANOUS 3 0.0026
178 ENDOCARDITIS BACTERIAL 2 0.0025
179 BILE DUCT CANCER 3 0.0025
180 BEDRIDDEN 33 0.0025
181 CHRONIC RESPIRATORY FAILURE 3 0.0025
182 SQUAMOUS CELL CARCINOMA OF SKIN 15 0.0025
183 CONTRAINDICATED PRODUCT ADMINISTERED 75 0.0025
184 RESPIRATION ABNORMAL 17 0.0025
185 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 16 0.0025
186 MONOCYTE COUNT DECREASED 3 0.0025
187 COORDINATION ABNORMAL 34 0.0024
188 COLLAPSE OF LUNG 2 0.0024
189 TROPONIN I INCREASED 4 0.0024
190 NEUTROPHIL PERCENTAGE INCREASED 3 0.0024
191 SINUS CONGESTION 32 0.0024
192 EXOPHTHALMOS 5 0.0023
193 ASPERGILLOSIS 3 0.0023
194 ACQUIRED GENE MUTATION 3 0.0023
195 GASTROINTESTINAL FISTULA 2 0.0023
196 HYPOGAMMAGLOBULINAEMIA 15 0.0023
197 APPETITE DISORDER 15 0.0023
198 PAROSMIA 17 0.0023
199 LARGE INTESTINAL OBSTRUCTION 5 0.0022
200 LYMPHOCYTE PERCENTAGE DECREASED 3 0.0022
201 RHINITIS 18 0.0022
202 HYPERPLASIA 2 0.0022
203 MUCOSAL EROSION 2 0.0022
204 CORNEAL OPACITY 3 0.0022
205 CUSHINGOID 7 0.0022
206 CYTOMEGALOVIRUS COLITIS 5 0.0022
207 MUSCLE INJURY 18 0.0022
208 ECHOCARDIOGRAM ABNORMAL 3 0.0021
209 GINGIVAL PAIN 17 0.0021
210 PORPHYRIA ACUTE 3 0.0021
211 SKIN HAEMORRHAGE 31 0.0021
212 CARDIAC MURMUR 18 0.0021
213 VISUAL ACUITY REDUCED 69 0.0021
214 DUST ALLERGY 2 0.0020
215 MYASTHENIA GRAVIS CRISIS 3 0.0020
216 HEMIPARESIS 34 0.0020
217 LIP DRY 18 0.0020
218 CATHETER RELATED INFECTION 2 0.0020
219 BRAIN ABSCESS 5 0.0020
220 RESPIRATORY TRACT CONGESTION 31 0.0019
221 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 4 0.0019
222 ENTEROCOCCAL BACTERAEMIA 2 0.0019
223 TREATMENT FAILURE 156 0.0019
224 PULMONARY TUBERCULOSIS 8 0.0019
225 ANGINA PECTORIS 53 0.0018
226 EXPOSED BONE IN JAW 4 0.0018
227 CRYPTOCOCCOSIS 3 0.0018
228 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 31 0.0018
229 AORTIC DILATATION 2 0.0018
230 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 3 0.0018
231 LUNG CONSOLIDATION 5 0.0018
232 WHEEZING 105 0.0018
233 DISLOCATION OF VERTEBRA 4 0.0018
234 PNEUMATOSIS INTESTINALIS 5 0.0018
235 CYTOMEGALOVIRUS INFECTION 29 0.0017
236 FOOT FRACTURE 33 0.0017
237 RETINITIS 3 0.0017
238 MUCOSAL HAEMORRHAGE 2 0.0017
239 C-REACTIVE PROTEIN ABNORMAL 11 0.0017
240 PSEUDOMONAL SEPSIS 3 0.0017
241 BRONCHIOLITIS 6 0.0017
242 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 3 0.0017
243 BONE EROSION 6 0.0017
244 HISTOPLASMOSIS 3 0.0017
245 BRONCHOPULMONARY ASPERGILLOSIS 13 0.0017
246 ASPERGILLUS INFECTION 11 0.0017
247 CEREBRAL VENOUS THROMBOSIS 3 0.0017
248 ENCEPHALITIS VIRAL 2 0.0016
249 PNEUMOPERITONEUM 3 0.0016
250 STAPHYLOCOCCAL SEPSIS 8 0.0016
251 SINUS DISORDER 32 0.0016
252 FRACTURED SACRUM 2 0.0016
253 FLANK PAIN 15 0.0016
254 VENTRICULAR HYPERTROPHY 4 0.0016
255 PNEUMOCYSTIS JIROVECII PNEUMONIA 16 0.0016
256 GASTRIC ULCER PERFORATION 2 0.0016
257 HYPERCOAGULATION 3 0.0016
258 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 6 0.0016
259 CARDIAC VENTRICULAR THROMBOSIS 2 0.0015
260 PNEUMONIA CYTOMEGALOVIRAL 3 0.0015
261 RHINOVIRUS INFECTION 6 0.0015
262 LIVER ABSCESS 5 0.0015
263 CYTOMEGALOVIRUS CHORIORETINITIS 3 0.0015
264 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 3 0.0015
265 GENE MUTATION 3 0.0015
266 EMPYEMA 3 0.0015
267 JOINT RANGE OF MOTION DECREASED 20 0.0015
268 UPPER RESPIRATORY TRACT INFECTION 68 0.0015
269 VARICELLA ZOSTER VIRUS INFECTION 3 0.0014
270 DEATH NEONATAL 2 0.0014
271 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 68 0.0014
272 EATING DISORDER 30 0.0014
273 MENINGITIS BACTERIAL 2 0.0014
274 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 10 0.0014
275 KLEBSIELLA INFECTION 7 0.0014
276 OEDEMA 75 0.0014
277 SNEEZING 31 0.0014
278 SWOLLEN TONGUE 43 0.0014
279 PEMPHIGUS 17 0.0014
280 DUODENAL ULCER PERFORATION 10 0.0013
281 COMPLICATIONS OF TRANSPLANTED KIDNEY 3 0.0013
282 ASTIGMATISM 2 0.0013
283 FUNGAL PERITONITIS 2 0.0013
284 VASCULITIS 15 0.0013
285 ESCHERICHIA BACTERAEMIA 3 0.0013
286 ASTHMA 144 0.0013
287 MEGACOLON 2 0.0013
288 HISTOPLASMOSIS DISSEMINATED 2 0.0013
289 JC VIRUS INFECTION 2 0.0013
290 WEIGHT ABNORMAL 3 0.0012
291 TRANSPLANT REJECTION 10 0.0012
292 ENTEROCOCCAL INFECTION 6 0.0012
293 EYE PAIN 70 0.0012
294 GASTROINTESTINAL INFECTION 11 0.0012
295 RED CELL DISTRIBUTION WIDTH INCREASED 5 0.0012
296 OLIGOHYDRAMNIOS 4 0.0012
297 HELICOBACTER INFECTION 12 0.0012
298 OSTEOPOROSIS 48 0.0012
299 FRACTURE 22 0.0012
300 STAPHYLOCOCCAL BACTERAEMIA 5 0.0011
301 RHEUMATOID ARTHRITIS 130 0.0011
302 NAIL DISORDER 10 0.0011
303 CYTOMEGALOVIRUS VIRAEMIA 5 0.0011
304 MYCOBACTERIUM AVIUM COMPLEX INFECTION 3 0.0011
305 JOINT ARTHROPLASTY 2 0.0011
306 LARYNGOSPASM 3 0.0011
307 WEIGHT BEARING DIFFICULTY 3 0.0011
308 RESPIRATORY TRACT INFECTION 29 0.0011
309 IMPAIRED QUALITY OF LIFE 16 0.0011
310 SYNOVITIS 20 0.0011
311 ULCERATIVE KERATITIS 3 0.0011
312 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 9 0.0011
313 CALCIPHYLAXIS 2 0.0011
314 DRUG LEVEL BELOW THERAPEUTIC 6 0.0011
315 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 3 0.0011
316 STREPTOCOCCAL INFECTION 6 0.0011
317 LEUKOENCEPHALOPATHY 4 0.0011
318 LUPUS NEPHRITIS 2 0.0011
319 CYSTITIS 34 0.0011
320 PROTEIN TOTAL DECREASED 4 0.0011
321 INTERVERTEBRAL DISCITIS 2 0.0011
322 APHASIA 32 0.0011
323 HYPOPROTEINAEMIA 2 0.0011
324 MECHANICAL VENTILATION 2 0.0011
325 MENINGITIS 7 0.0010
326 ARTERIAL THROMBOSIS 2 0.0010
327 RESPIRATORY SYNCYTIAL VIRUS INFECTION 9 0.0010
328 LOWER RESPIRATORY TRACT INFECTION 47 0.0010
329 ADRENOCORTICAL INSUFFICIENCY ACUTE 2 0.0010
330 APLASIA 2 0.0010
331 SYSTEMIC LUPUS ERYTHEMATOSUS 36 0.0010
332 ENCEPHALITIS 7 0.0010
333 FLUID RETENTION 51 0.0010
334 OBSESSIVE-COMPULSIVE DISORDER 8 0.0010
335 HEPATITIS B 6 0.0010
336 IRITIS 3 0.0010
337 FOETAL GROWTH RESTRICTION 6 0.0010
338 MALNUTRITION 11 0.0010
339 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 2 0.0010
340 NEUTROPENIC SEPSIS 7 0.0010
341 CHEST X-RAY ABNORMAL 3 0.0010
342 OSTEONECROSIS 32 0.0010
343 INSULIN RESISTANCE 2 0.0010
344 TUBULOINTERSTITIAL NEPHRITIS 18 0.0010
345 EOSINOPHIL COUNT INCREASED 8 0.0010
346 LUNG ABSCESS 2 0.0010
347 PERICARDITIS 16 0.0010
348 DILATATION VENTRICULAR 2 0.0010
349 ELECTROLYTE IMBALANCE 11 0.0009
350 FIBROMYALGIA 23 0.0009
351 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 9 0.0009
352 RASH ERYTHEMATOUS 45 0.0009
353 PNEUMONIA VIRAL 3 0.0009
354 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 2 0.0009
355 CD4 LYMPHOCYTES DECREASED 2 0.0009
356 HERPES SIMPLEX 6 0.0009
357 TOXIC EPIDERMAL NECROLYSIS 14 0.0009
358 INFUSION RELATED REACTION 61 0.0009
359 LYMPHOCYTE COUNT INCREASED 3 0.0009
360 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 2 0.0009
361 ABDOMINAL ABSCESS 4 0.0009
362 CALCINOSIS 2 0.0009
363 HEPATIC ENZYME INCREASED 61 0.0009
364 CORNEAL OEDEMA 2 0.0009
365 COMPUTERISED TOMOGRAM ABNORMAL 2 0.0009
366 DYSARTHRIA 33 0.0009
367 METASTATIC MALIGNANT MELANOMA 2 0.0009
368 ENTEROCOLITIS 5 0.0009
369 FOLLICULITIS 9 0.0009
370 DISSEMINATED INTRAVASCULAR COAGULATION 12 0.0009
371 NECROTISING FASCIITIS 3 0.0009
372 EXPOSURE DURING PREGNANCY 52 0.0008
373 RHINORRHOEA 54 0.0008
374 BASAL CELL CARCINOMA 13 0.0008
375 CHRONIC GRAFT VERSUS HOST DISEASE 3 0.0008
376 ARTHRITIS 65 0.0008
377 MONOCYTE COUNT INCREASED 3 0.0008
378 AUTOIMMUNE DISORDER 8 0.0008
379 JUVENILE IDIOPATHIC ARTHRITIS 2 0.0008
380 PSEUDOMONAS INFECTION 7 0.0008
381 INSTILLATION SITE PAIN 2 0.0008
382 SEPTIC SHOCK 35 0.0008
383 IMPAIRED WORK ABILITY 17 0.0008
384 LUNG INFILTRATION 7 0.0008
385 DERMATOMYOSITIS 2 0.0008
386 SCREAMING 5 0.0008
387 OESOPHAGEAL ULCER 3 0.0008
388 HEPATOSPLENOMEGALY 2 0.0008
389 MEAN CELL VOLUME INCREASED 2 0.0008
390 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 55 0.0008
391 CANDIDA INFECTION 13 0.0008
392 DRUG INTOLERANCE 74 0.0008
393 LUNG OPACITY 2 0.0008
394 OBESITY 12 0.0008
395 SQUAMOUS CELL CARCINOMA 7 0.0007
396 FREQUENT BOWEL MOVEMENTS 20 0.0007
397 NO THERAPEUTIC RESPONSE 9 0.0007
398 MOBILITY DECREASED 53 0.0007
399 HYPERSENSITIVITY 136 0.0007
400 RESPIRATORY DISTRESS 20 0.0007
401 CATARACT 43 0.0007
402 HALLUCINATIONS, MIXED 3 0.0007
403 FORCED EXPIRATORY VOLUME DECREASED 2 0.0007
404 RETCHING 15 0.0007
405 LEUKOPENIA 35 0.0007
406 GRAFT VERSUS HOST DISEASE 5 0.0007
407 ADENOVIRUS INFECTION 2 0.0007
408 HYPERGLYCAEMIA 25 0.0007
409 GROWTH RETARDATION 2 0.0007
410 RESPIRATORY RATE INCREASED 6 0.0007
411 BACTERAEMIA 8 0.0007
412 INFUSION SITE REACTION 2 0.0007
413 BLOOD CULTURE POSITIVE 2 0.0007
414 LUNG ADENOCARCINOMA 2 0.0007
415 HEPATITIS 17 0.0007
416 PAPILLOEDEMA 3 0.0007
417 ADRENAL INSUFFICIENCY 8 0.0007
418 EYE INJURY 2 0.0007
419 KERATITIS 2 0.0007
420 RETINAL DETACHMENT 6 0.0007
421 DUODENITIS 2 0.0007
422 LIVER INJURY 16 0.0007
423 ECTOPIC PREGNANCY 2 0.0006
424 DIFFUSE LARGE B-CELL LYMPHOMA 5 0.0006
425 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 5 0.0006
426 ACUTE MYELOID LEUKAEMIA 10 0.0006
427 WOUND INFECTION 7 0.0006
428 BLOOD CREATININE DECREASED 2 0.0006
429 IRIDOCYCLITIS 2 0.0006
430 RED BLOOD CELL SEDIMENTATION RATE INCREASED 7 0.0006
431 BLOOD LACTATE DEHYDROGENASE INCREASED 10 0.0006
432 HEPATIC FAILURE 19 0.0006
433 GESTATIONAL DIABETES 3 0.0006
434 LOW BIRTH WEIGHT BABY 5 0.0006
435 STILLBIRTH 3 0.0006
436 ATELECTASIS 6 0.0006
437 BREAST CANCER STAGE III 4 0.0006
438 HYPOVENTILATION 2 0.0006
439 HAND DEFORMITY 8 0.0006
440 BREATH SOUNDS ABNORMAL 3 0.0006
441 WOUND 17 0.0006
442 THROMBOCYTOPENIA 68 0.0006
443 VENOOCCLUSIVE LIVER DISEASE 3 0.0006
444 PULMONARY MASS 9 0.0006
445 EXPOSURE DURING BREAST FEEDING 2 0.0006
446 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 3 0.0006
447 DERMATITIS EXFOLIATIVE 3 0.0006
448 PREGNANCY 12 0.0006
449 HAEMODIALYSIS 5 0.0006
450 BK VIRUS INFECTION 2 0.0006
451 PATHOLOGICAL FRACTURE 3 0.0006
452 PSORIASIS 77 0.0006
453 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 4 0.0006
454 ANGIOEDEMA 26 0.0006
455 ENDOCARDITIS 3 0.0006
456 NEPHROTIC SYNDROME 4 0.0006
457 ANAPHYLACTIC SHOCK 15 0.0006
458 APLASIA PURE RED CELL 2 0.0006
459 CHEST DISCOMFORT 59 0.0006
460 PULMONARY HYPERTENSION 12 0.0006
461 MEDICATION ERROR 32 0.0006
462 HYPERREFLEXIA 2 0.0006
463 IMMUNOSUPPRESSION 5 0.0006
464 CLOSTRIDIUM DIFFICILE COLITIS 6 0.0006
465 HEART DISEASE CONGENITAL 2 0.0006
466 PURPURA 5 0.0006
467 SEPSIS 63 0.0006
468 MULTIPLE ORGAN DYSFUNCTION SYNDROME 16 0.0006
469 SCIATICA 9 0.0006
470 JOINT SWELLING 68 0.0006
471 FIBRIN D DIMER INCREASED 2 0.0006
472 GENERAL PHYSICAL HEALTH DETERIORATION 65 0.0006
473 COLITIS ULCERATIVE 25 0.0006
474 CONDITION AGGRAVATED 170 0.0006
475 SKIN EXFOLIATION 47 0.0006
476 INFLUENZA 62 0.0006
477 PARAESTHESIA ORAL 8 0.0006
478 PRODUCT USE ISSUE 104 0.0006
479 PYREXIA 191 0.0006
480 LUNG DISORDER 27 0.0006
481 HYPOPHAGIA 14 0.0005
482 HYPERTENSIVE CRISIS 6 0.0005
483 GASTROINTESTINAL DISORDER 48 0.0005
484 PULMONARY ALVEOLAR HAEMORRHAGE 3 0.0005
485 DYSPNOEA EXERTIONAL 20 0.0005
486 HYPOCALCAEMIA 10 0.0005
487 NIGHT SWEATS 17 0.0005
488 TROPONIN INCREASED 4 0.0005
489 NEUROLOGICAL SYMPTOM 3 0.0005
490 HYPERTONIA 3 0.0005
491 PRODUCTIVE COUGH 25 0.0005
492 ACIDOSIS 4 0.0005
493 PULMONARY FIBROSIS 10 0.0005
494 NIGHTMARE 18 0.0005
495 ACCIDENTAL OVERDOSE 19 0.0005
496 EJECTION FRACTION DECREASED 8 0.0005
497 INTENTIONAL PRODUCT USE ISSUE 45 0.0005
498 PRODUCT ADMINISTRATION INTERRUPTED 4 0.0005
499 DECREASED IMMUNE RESPONSIVENESS 5 0.0005
500 GLUCOSE TOLERANCE IMPAIRED 3 0.0005
501 DYSPHAGIA 48 0.0005
502 PNEUMOTHORAX 8 0.0005
503 TRICUSPID VALVE INCOMPETENCE 4 0.0005
504 INTENTIONAL PRODUCT MISUSE 44 0.0005
505 HEPATITIS CHOLESTATIC 3 0.0005
506 SLEEP DISORDER 35 0.0005
507 PNEUMONIA 159 0.0005
508 HYPERHIDROSIS 63 0.0005
509 ANAPHYLACTOID REACTION 2 0.0005
510 TENDON RUPTURE 6 0.0005
511 PERICARDIAL EFFUSION 11 0.0005
512 POOR QUALITY PRODUCT ADMINISTERED 5 0.0005
513 LIVER DISORDER 21 0.0005
514 AORTIC VALVE INCOMPETENCE 2 0.0005
515 SINUSITIS 48 0.0005
516 RECTAL HAEMORRHAGE 20 0.0005
517 HIP ARTHROPLASTY 7 0.0005
518 TUMOUR LYSIS SYNDROME 4 0.0005
519 ROAD TRAFFIC ACCIDENT 19 0.0005
520 ARTERIOSCLEROSIS CORONARY ARTERY 3 0.0005
521 FOOT DEFORMITY 5 0.0005
522 CATHETERISATION CARDIAC 2 0.0005
523 OSTEOARTHRITIS 19 0.0004
524 ILEUS PARALYTIC 2 0.0004
525 MENINGITIS ASEPTIC 2 0.0004
526 POSTOPERATIVE WOUND INFECTION 3 0.0004
527 PSORIATIC ARTHROPATHY 18 0.0004
528 TACHYPNOEA 6 0.0004
529 PNEUMONITIS 12 0.0004
530 MUSCULAR WEAKNESS 50 0.0004
531 CARDIAC DISORDER 41 0.0004
532 EYE MOVEMENT DISORDER 3 0.0004
533 ACUTE GRAFT VERSUS HOST DISEASE 2 0.0004
534 LUMBAR VERTEBRAL FRACTURE 2 0.0004
535 PALPITATIONS 51 0.0004
536 DROOLING 3 0.0004
537 HYPERTRANSAMINASAEMIA 3 0.0004
538 SPLENOMEGALY 5 0.0004
539 DUODENAL ULCER 3 0.0004
540 LYMPHOPENIA 6 0.0004
541 CARDIAC TAMPONADE 2 0.0004
542 PROTEINURIA 8 0.0004
543 CONFUSIONAL STATE 68 0.0004
544 IRRITABLE BOWEL SYNDROME 9 0.0004
545 INJURY 29 0.0004
546 NASOPHARYNGITIS 76 0.0004
547 STOMATITIS 25 0.0004
548 UTERINE LEIOMYOMA 3 0.0004
549 NASAL CONGESTION 24 0.0004
550 ASCITES 12 0.0004
551 CARDIOMEGALY 5 0.0004
552 GLOSSODYNIA 9 0.0004
553 ECZEMA 21 0.0004
554 HEPATIC ENZYME ABNORMAL 2 0.0004
555 INFLUENZA LIKE ILLNESS 33 0.0004
556 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 3 0.0004
557 HYPOXIA 14 0.0004
558 IMPAIRED HEALING 13 0.0004
559 FEELING COLD 11 0.0004
560 HEPATOCELLULAR CARCINOMA 3 0.0004
561 HAEMATEMESIS 10 0.0004
562 STAPHYLOCOCCAL INFECTION 13 0.0004
563 FEBRILE NEUTROPENIA 26 0.0004
564 VOMITING 184 0.0004
565 HYPOKALAEMIA 18 0.0004
566 DEVICE RELATED INFECTION 6 0.0004
567 GAIT INABILITY 13 0.0004
568 CEREBRAL ISCHAEMIA 2 0.0004
569 POOR VENOUS ACCESS 4 0.0004
570 TYPE 2 DIABETES MELLITUS 13 0.0004
571 BLOOD CHOLESTEROL INCREASED 18 0.0004
572 FAILURE TO THRIVE 2 0.0004
573 RESPIRATORY FAILURE 28 0.0004
574 PULMONARY HAEMORRHAGE 3 0.0004
575 MULTIPLE ALLERGIES 3 0.0004
576 WEIGHT FLUCTUATION 4 0.0004
577 ORAL CANDIDIASIS 5 0.0004
578 JOINT DISLOCATION 4 0.0004
579 FULL BLOOD COUNT ABNORMAL 4 0.0004
580 BACTERIAL INFECTION 7 0.0004
581 INFECTION 54 0.0004
582 JAUNDICE 10 0.0004
583 TINNITUS 17 0.0004
584 DEEP VEIN THROMBOSIS 24 0.0004
585 SHOCK HAEMORRHAGIC 3 0.0004
586 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 2 0.0004
587 EYE DISORDER 12 0.0004
588 ESCHERICHIA INFECTION 3 0.0004
589 ACUTE RESPIRATORY FAILURE 7 0.0004
590 COUGH 102 0.0004
591 DYSGEUSIA 27 0.0004
592 SPINAL COMPRESSION FRACTURE 3 0.0004
593 HAEMATOCHEZIA 20 0.0004
594 BREAST CANCER STAGE II 3 0.0004
595 VENTRICULAR FIBRILLATION 4 0.0004
596 COAGULOPATHY 6 0.0004
597 HEPATOTOXICITY 8 0.0004
598 INTRACRANIAL PRESSURE INCREASED 2 0.0004
599 SWELLING FACE 23 0.0004
600 CHOLECYSTITIS ACUTE 2 0.0004
601 CAESAREAN SECTION 4 0.0003
602 DYSPHONIA 20 0.0003
603 NEUTROPENIA 46 0.0003
604 HYPONATRAEMIA 19 0.0003
605 HYPERTENSION 71 0.0003
606 MUSCLE RIGIDITY 4 0.0003
607 THERAPY NON-RESPONDER 15 0.0003
608 KNEE ARTHROPLASTY 7 0.0003
609 LUPUS-LIKE SYNDROME 3 0.0003
610 INTERSTITIAL LUNG DISEASE 16 0.0003
611 FUNGAL INFECTION 11 0.0003
612 HYPOGLYCAEMIA 16 0.0003
613 INFLAMMATION 17 0.0003
614 EXOSTOSIS 3 0.0003
615 LIVER FUNCTION TEST INCREASED 7 0.0003
616 DYSURIA 12 0.0003
617 MATERNAL EXPOSURE DURING PREGNANCY 29 0.0003
618 GRAND MAL CONVULSION 3 0.0003
619 MUSCULOSKELETAL PAIN 17 0.0003
620 GENERALISED OEDEMA 4 0.0003
621 CHOLANGITIS 2 0.0003
622 PANCYTOPENIA 18 0.0003
623 ERYTHEMA MULTIFORME 3 0.0003
624 DIARRHOEA HAEMORRHAGIC 3 0.0003
625 ARTERIOSCLEROSIS 3 0.0003
626 GAMMA-GLUTAMYLTRANSFERASE INCREASED 7 0.0003
627 RECALLED PRODUCT ADMINISTERED 3 0.0003
628 FOREIGN BODY SENSATION IN EYES 2 0.0003
629 VERTIGO 19 0.0003
630 DRUG RESISTANCE 8 0.0003
631 CHEST PAIN 57 0.0003
632 HEPATITIS ACUTE 2 0.0003
633 PULMONARY EMBOLISM 29 0.0003
634 LABORATORY TEST ABNORMAL 9 0.0003
635 HAEMATOCRIT DECREASED 6 0.0003
636 C-REACTIVE PROTEIN INCREASED 11 0.0003
637 PSYCHOMOTOR HYPERACTIVITY 5 0.0003
638 CEREBROVASCULAR ACCIDENT 51 0.0003
639 VIRAL INFECTION 10 0.0003
640 SALIVARY HYPERSECRETION 3 0.0003
641 BLOOD UREA INCREASED 5 0.0003
642 ANGER 10 0.0003
643 GENERAL PHYSICAL CONDITION ABNORMAL 2 0.0003
644 CIRCULATORY COLLAPSE 5 0.0003
645 NEUTROPHIL COUNT INCREASED 3 0.0003
646 LARGE INTESTINE PERFORATION 2 0.0003
647 AUTOIMMUNE HEPATITIS 2 0.0003
648 DEPRESSED MOOD 15 0.0003
649 ACUTE RESPIRATORY DISTRESS SYNDROME 5 0.0003
650 SEASONAL ALLERGY 4 0.0003
651 MOOD SWINGS 9 0.0003
652 PNEUMONIA ASPIRATION 7 0.0003
653 DISCOMFORT 17 0.0003
654 ADVERSE DRUG REACTION 25 0.0003
655 FAECES DISCOLOURED 6 0.0003
656 MUSCULOSKELETAL STIFFNESS 24 0.0003
657 ASPIRATION 3 0.0003
658 BLINDNESS TRANSIENT 2 0.0003
659 OEDEMA PERIPHERAL 33 0.0003
660 HYPOPHOSPHATAEMIA 2 0.0003
661 ARTHROPOD BITE 2 0.0003
662 OBSTRUCTIVE AIRWAYS DISORDER 3 0.0003
663 OCULAR DISCOMFORT 3 0.0003
664 RASH 116 0.0003
665 REBOUND EFFECT 3 0.0003
666 BLOOD SODIUM DECREASED 5 0.0003
667 MITRAL VALVE INCOMPETENCE 3 0.0003
668 MYOCARDIAL ISCHAEMIA 3 0.0003
669 HAEMODYNAMIC INSTABILITY 2 0.0003
670 DIABETES MELLITUS 20 0.0003
671 HYPERTHERMIA 2 0.0003
672 MYOCARDITIS 3 0.0003
673 CONSTIPATION 57 0.0003
674 LUNG INFECTION 4 0.0003
675 APNOEA 2 0.0003
676 SWELLING 24 0.0003
677 COVID-19 PNEUMONIA 3 0.0003
678 BLOOD ALBUMIN DECREASED 2 0.0003
679 CHOLECYSTITIS 3 0.0003
680 ABSCESS 4 0.0003
681 ERYTHEMA 51 0.0002
682 BONE MARROW FAILURE 5 0.0002
683 BACK DISORDER 4 0.0002
684 CEREBRAL INFARCTION 6 0.0002
685 BRADYCARDIA 13 0.0002
686 BLOOD CREATINE PHOSPHOKINASE INCREASED 7 0.0002
687 PAIN 149 0.0002
688 OSTEONECROSIS OF JAW 6 0.0002
689 BLOOD PRESSURE INCREASED 37 0.0002
690 HEADACHE 151 0.0002
691 UPPER GASTROINTESTINAL HAEMORRHAGE 4 0.0002
692 TACHYCARDIA 21 0.0002
693 MALAISE 103 0.0002
694 SCAR 4 0.0002
695 BACK PAIN 54 0.0002
696 ANURIA 2 0.0002
697 BLISTER 13 0.0002
698 MULTI-ORGAN FAILURE 4 0.0002
699 PLATELET COUNT INCREASED 3 0.0002
700 DEAFNESS 6 0.0002
701 PULMONARY CONGESTION 3 0.0002
702 DEPRESSED LEVEL OF CONSCIOUSNESS 9 0.0002
703 ABNORMAL BEHAVIOUR 9 0.0002
704 OFF LABEL USE 196 0.0002
705 THROMBOSIS 18 0.0002
706 THERAPEUTIC PRODUCT EFFECT DECREASED 10 0.0002
707 MIGRAINE 21 0.0002
708 ANXIETY 62 0.0002
709 ADVERSE EVENT 20 0.0002
710 DYSPNOEA 122 0.0002
711 HYPOMAGNESAEMIA 3 0.0002
712 ABDOMINAL DISCOMFORT 36 0.0002
713 HEPATIC ENCEPHALOPATHY 2 0.0002
714 PRODUCT USE IN UNAPPROVED INDICATION 53 0.0002
715 OVERDOSE 46 0.0002
716 HEPATIC CIRRHOSIS 4 0.0002
717 SINUS TACHYCARDIA 3 0.0002
718 RED BLOOD CELL COUNT DECREASED 6 0.0002
719 MYELODYSPLASTIC SYNDROME 3 0.0002
720 ASPARTATE AMINOTRANSFERASE INCREASED 11 0.0002
721 KIDNEY INFECTION 4 0.0002
722 HEPATOMEGALY 2 0.0002
723 ACUTE MYOCARDIAL INFARCTION 6 0.0002
724 DELIRIUM 7 0.0002
725 BLADDER DISORDER 2 0.0002
726 UPPER LIMB FRACTURE 4 0.0002
727 CARDIAC FAILURE 16 0.0002
728 SEIZURE 23 0.0002
729 HOT FLUSH 15 0.0002
730 PLEURAL EFFUSION 12 0.0002
731 EYELID PTOSIS 2 0.0002
732 DRUG DISPENSING ERROR 3 0.0002
733 CEREBRAL HAEMORRHAGE 7 0.0002
734 TENDONITIS 3 0.0002
735 PERITONITIS 4 0.0002
736 DELUSION 3 0.0002
737 FATIGUE 150 0.0002
738 EYE DISCHARGE 2 0.0002
739 RESTLESSNESS 7 0.0002
740 CYANOSIS 3 0.0002
741 JOINT STIFFNESS 5 0.0002
742 INCONTINENCE 2 0.0002
743 METABOLIC ACIDOSIS 6 0.0002
744 HEPATIC FUNCTION ABNORMAL 7 0.0002
745 WEIGHT INCREASED 42 0.0002
746 HEREDITARY ANGIOEDEMA 2 0.0002
747 BLOOD BILIRUBIN INCREASED 5 0.0002
748 RASH PRURITIC 10 0.0002
749 PARAESTHESIA 29 0.0002
750 PRODUCT PRESCRIBING ISSUE 4 0.0002
751 COVID-19 32 0.0002
752 MELAENA 4 0.0002
753 VENTRICULAR TACHYCARDIA 3 0.0002
754 DENTAL CARIES 2 0.0002
755 HYPOAESTHESIA 27 0.0002
756 STEVENS-JOHNSON SYNDROME 4 0.0002
757 AGGRESSION 9 0.0002
758 HAEMOPTYSIS 5 0.0002
759 CELLULITIS 9 0.0002
760 INTESTINAL PERFORATION 2 0.0002
761 FISTULA 2 0.0002
762 FACE OEDEMA 3 0.0002
763 FALL 59 0.0002
764 DRUG EXPOSURE DURING PREGNANCY 6 0.0002
765 INTENTIONAL DOSE OMISSION 5 0.0002
766 DERMATITIS CONTACT 2 0.0002
767 MICTURITION URGENCY 2 0.0002
768 MUSCLE SPASMS 32 0.0002
769 SHOCK 4 0.0002
770 METASTASES TO LUNG 2 0.0002
771 DYSKINESIA 7 0.0002
772 EYELID OEDEMA 2 0.0002
773 LOCAL SWELLING 3 0.0002
774 LYMPHOCYTE COUNT DECREASED 3 0.0002
775 ISCHAEMIC STROKE 3 0.0002
776 COMA 8 0.0002
777 ABDOMINAL PAIN 39 0.0002
778 HYPERLIPIDAEMIA 2 0.0002
779 RESPIRATORY DISORDER 5 0.0002
780 OSTEOMYELITIS 3 0.0002
781 CRYING 6 0.0002
782 WEIGHT DECREASED 46 0.0002
783 BONE DISORDER 3 0.0002
784 ILL-DEFINED DISORDER 10 0.0002
785 DRUG INEFFECTIVE 215 0.0002
786 ENCEPHALOPATHY 4 0.0002
787 HYPERCALCAEMIA 2 0.0002
788 ABNORMAL WEIGHT GAIN 2 0.0002
789 ARTHRALGIA 67 0.0002
790 MIDDLE INSOMNIA 3 0.0002
791 OXYGEN SATURATION DECREASED 9 0.0002
792 DRUG-INDUCED LIVER INJURY 5 0.0002
793 BRAIN OEDEMA 2 0.0002
794 NEUROPATHY PERIPHERAL 15 0.0002
795 GLAUCOMA 3 0.0002
796 METASTASES TO CENTRAL NERVOUS SYSTEM 2 0.0002
797 RASH GENERALISED 4 0.0002
798 EAR PAIN 3 0.0002
799 PHARMACEUTICAL PRODUCT COMPLAINT 4 0.0002
800 ORAL HERPES 3 0.0002
801 SKIN FISSURES 3 0.0002
802 IMMUNE SYSTEM DISORDER 2 0.0002
803 CYTOKINE RELEASE SYNDROME 3 0.0001
804 PERIPHERAL SWELLING 23 0.0001
805 MALIGNANT MELANOMA 2 0.0001
806 URTICARIA 25 0.0001
807 OCULAR HYPERAEMIA 7 0.0001
808 BLINDNESS 6 0.0001
809 DISEASE RECURRENCE 7 0.0001
810 PALLOR 4 0.0001
811 ALANINE AMINOTRANSFERASE INCREASED 9 0.0001
812 ASTHENIA 55 0.0001
813 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
814 MENTAL STATUS CHANGES 4 0.0001
815 ARTHROPATHY 8 0.0001
816 GASTROINTESTINAL HAEMORRHAGE 12 0.0001
817 DERMATITIS 3 0.0001
818 MASS 2 0.0001
819 CARPAL TUNNEL SYNDROME 2 0.0001
820 PRODUCT DOSE OMISSION IN ERROR 4 0.0001
821 LYMPHADENOPATHY 5 0.0001
822 HYPERSOMNIA 4 0.0001
823 CARDIOGENIC SHOCK 2 0.0001
824 POOR QUALITY SLEEP 3 0.0001
825 HYPERTHYROIDISM 2 0.0001
826 HYPOKINESIA 2 0.0001
827 PRODUCT DISPENSING ERROR 3 0.0001
828 CLOSTRIDIUM DIFFICILE INFECTION 3 0.0001
829 CONTUSION 13 0.0001
830 SOMNOLENCE 27 0.0001
831 HAEMORRHAGE INTRACRANIAL 2 0.0001
832 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 24 0.0001
833 HYPOAESTHESIA ORAL 2 0.0001
834 INTESTINAL OBSTRUCTION 5 0.0001
835 PANCREATITIS 7 0.0001
836 ECONOMIC PROBLEM 2 0.0001
837 ANKLE FRACTURE 2 0.0001
838 PAIN IN EXTREMITY 38 0.0001
839 DEHYDRATION 17 0.0001
840 HAEMOGLOBIN DECREASED 13 0.0001
841 MENTAL IMPAIRMENT 3 0.0001
842 DEPRESSION 28 0.0001
843 LETHARGY 7 0.0001
844 LUNG NEOPLASM MALIGNANT 5 0.0001
845 MANIA 2 0.0001
846 SUICIDAL IDEATION 11 0.0001
847 INSOMNIA 32 0.0001
848 LIP SWELLING 4 0.0001
849 SKIN DISORDER 4 0.0001
850 URINARY TRACT INFECTION 20 0.0001
851 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
852 IRRITABILITY 7 0.0001
853 UNRESPONSIVE TO STIMULI 3 0.0001
854 SKIN ULCER 3 0.0001
855 NEOPLASM PROGRESSION 4 0.0001
856 NAUSEA 91 0.0001
857 DERMATITIS ATOPIC 6 0.0001
858 EAR INFECTION 3 0.0001
859 DECREASED APPETITE 26 0.0001
860 PULMONARY OEDEMA 5 0.0001
861 DRY MOUTH 9 0.0001
862 THROAT TIGHTNESS 3 0.0001
863 DISEASE PROGRESSION 13 0.0001
864 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 6 0.0001
865 MYOCARDIAL INFARCTION 19 0.0001
866 ANAPHYLACTIC REACTION 6 0.0001
867 BRONCHITIS 8 0.0001
868 EYE SWELLING 4 0.0001
869 HEPATIC STEATOSIS 2 0.0001
870 DEMENTIA 3 0.0001
871 ILLNESS 11 0.0001
872 ARRHYTHMIA 5 0.0001
873 HAEMORRHAGE 11 0.0001
874 VISUAL IMPAIRMENT 13 0.0001
875 WHITE BLOOD CELL COUNT INCREASED 4 0.0001
876 CHOLESTASIS 2 0.0001
877 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
878 DIARRHOEA 66 0.0001
879 PSYCHOTIC DISORDER 3 0.0001
880 DISABILITY 2 0.0001
881 DISORIENTATION 4 0.0001
882 BLOOD POTASSIUM DECREASED 3 0.0001
883 ANAEMIA 19 0.0001
884 FULL BLOOD COUNT DECREASED 2 0.0001
885 INTENTIONAL SELF-INJURY 2 0.0001
886 FEEDING DISORDER 2 0.0001
887 NEUTROPHIL COUNT DECREASED 4 0.0001
888 EPILEPSY 3 0.0001
889 EMOTIONAL DISORDER 3 0.0001
890 CARDIAC ARREST 8 0.0001
891 RHABDOMYOLYSIS 4 0.0001
892 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 5 0.0001
893 CARDIO-RESPIRATORY ARREST 4 0.0001
894 RENAL IMPAIRMENT 8 0.0001
895 MOUTH ULCERATION 2 0.0001
896 RENAL FAILURE ACUTE 4 0.0001
897 DIZZINESS 47 0.0001
898 HYPOTHYROIDISM 3 0.0001
899 NO ADVERSE EVENT 17 0.0001
900 MOVEMENT DISORDER 3 0.0001
901 ABDOMINAL PAIN UPPER 19 0.0001
902 AMNESIA 6 0.0001
903 BLOOD CREATININE INCREASED 6 0.0001
904 DRUG WITHDRAWAL SYNDROME 8 0.0001
905 HEART RATE INCREASED 9 0.0001
906 RENAL FAILURE 12 0.0001
907 HYPOTENSION 18 0.0001
908 THROAT IRRITATION 4 0.0001
909 DRUG INTERACTION 14 0.0001
910 FLATULENCE 5 0.0001
911 HAEMATURIA 3 0.0001
912 CONVULSION 5 0.0001
913 SKIN DISCOLOURATION 4 0.0001
914 OROPHARYNGEAL PAIN 8 0.0001
915 LOSS OF CONSCIOUSNESS 11 0.0001
916 RASH MACULAR 3 0.0001
917 COGNITIVE DISORDER 4 0.0001
918 PRODUCT DOSE OMISSION ISSUE 25 0.0001
919 ACUTE KIDNEY INJURY 13 0.0001
920 DIABETIC KETOACIDOSIS 2 0.0001
921 UNDERDOSE 6 0.0001
922 ALOPECIA 16 0.0001
923 CARDIOVASCULAR DISORDER 2 0.0001
924 FLUSHING 8 0.0001
925 PRURITUS 30 0.0001
926 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0001
927 MUCOSAL INFLAMMATION 2 0.0001
928 FOETAL EXPOSURE DURING PREGNANCY 6 0.0001
929 LIMB INJURY 2 0.0001
930 MOOD ALTERED 2 0.0001
931 DIVERTICULITIS 2 0.0001
932 BURNING SENSATION 5 0.0001
933 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
934 HERPES ZOSTER 4 0.0001
935 EYE IRRITATION 4 0.0001
936 VAGINAL HAEMORRHAGE 3 0.0001
937 LIVER FUNCTION TEST ABNORMAL 2 0.0001
938 DYSSTASIA 2 0.0001
939 SURGERY 4 0.0001
940 DEVICE ISSUE 6 0.0001
941 HALLUCINATION 5 0.0001
942 UNEVALUABLE EVENT 5 0.0001
943 CORONARY ARTERY DISEASE 2 0.0001
944 PLATELET COUNT DECREASED 7 0.0001
945 MEMORY IMPAIRMENT 9 0.0001
946 FEELING HOT 4 0.0001
947 GAIT DISTURBANCE 12 0.0001
948 GASTROOESOPHAGEAL REFLUX DISEASE 5 0.0001
949 ATRIAL FIBRILLATION 6 0.0001
950 DRY EYE 3 0.0001
951 SYNCOPE 6 0.0001
952 CHILLS 7 0.0001
953 VISION BLURRED 8 0.0001
954 SPEECH DISORDER 3 0.0001
955 HEART RATE DECREASED 2 0.0001
956 DISTURBANCE IN ATTENTION 3 0.0001
957 TREATMENT NONCOMPLIANCE 3 0.0001
958 AGITATION 4 0.0001
959 NECK PAIN 3 0.0001
960 COLITIS 2 0.0001
961 ACNE 4 0.0001
962 HOSPITALISATION 8 0.0001
963 BONE PAIN 3 0.0001
964 THERAPEUTIC RESPONSE DECREASED 3 0.0000
965 TREMOR 8 0.0000
966 BLOOD GLUCOSE INCREASED 9 0.0000
967 MENTAL DISORDER 2 0.0000
968 DEATH 39 0.0000
969 INJECTION SITE REACTION 3 0.0000
970 TOXICITY TO VARIOUS AGENTS 7 0.0000
971 DYSPEPSIA 4 0.0000
972 CHRONIC KIDNEY DISEASE 3 0.0000
973 INCORRECT DOSE ADMINISTERED 9 0.0000
974 INJECTION SITE SWELLING 3 0.0000
975 INJECTION SITE HAEMORRHAGE 3 0.0000
976 WHITE BLOOD CELL COUNT DECREASED 4 0.0000
977 MYALGIA 6 0.0000
978 BREAST CANCER 3 0.0000
979 DRUG DOSE OMISSION 5 0.0000
980 BLOOD PRESSURE DECREASED 2 0.0000
981 ABDOMINAL DISTENSION 3 0.0000
982 EPISTAXIS 2 0.0000
983 INJECTION SITE PAIN 8 0.0000
984 CARDIAC FAILURE CONGESTIVE 2 0.0000
985 BALANCE DISORDER 2 0.0000
986 PRODUCT QUALITY ISSUE 3 0.0000
987 FEELING ABNORMAL 5 0.0000
988 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
989 INJECTION SITE ERYTHEMA 2 0.0000
990 DRY SKIN 2 0.0000
991 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000